Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia.

These preliminary findings suggest that the modified model of care continued to provide safe and effective treatment, during the pandemic. Notably, there was no association between more TAD and significant increases in substance use. Limitations are discussed and further evaluation is needed.